Clinical trial
Study of DITPA in Patients With Congestive Heart Failure
NCT00103519 · Titan Pharmaceuticals, Industry · Terminated
Key facts
| NCT number | NCT00103519 |
|---|---|
| Title | Study of DITPA in Patients With Congestive Heart Failure |
| Official title | A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of DITPA in Patients With NYHA Class III and IV Congestive Heart Failure Who Have Low Serum T3 Levels |
| Lead sponsor | Titan Pharmaceuticals, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Heart Failure, Congestive |
| Intervention type | Drug |
| Interventions | DITPA (3, 5-diiodothyropropionic acid), Placebo |
| Enrollment | 86 |
| Start date | Dec 1, 2004 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Feb 10, 2005 |
| Last update posted | Mar 29, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: